Liabilities and Equity of TC BioPharm (Holdings) plc from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit
us-gaap: GBP
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
TC BioPharm (Holdings) plc quarterly Liabilities and Equity in GBP history and change rate from 31 Dec 2022 to 31 Dec 2024.
  • TC BioPharm (Holdings) plc Liabilities and Equity for the quarter ending 31 Dec 2024 was £8,328,537, a 6.8% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (GBP)
Liabilities and Equity, YoY Quarterly Change (%)

TC BioPharm (Holdings) plc Quarterly Liabilities and Equity (GBP)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 £8,328,537 -£603,127 -6.8% 31 Dec 2024 20-F 09 May 2025 2024 FY
Q2 2024 £6,871,395 30 Jun 2024 6-K 25 Nov 2024 2024 Q2
Q1 2024 £7,264,053 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 £8,931,664 -£2,360,313 -21% 31 Dec 2023 20-F 09 May 2025 2024 FY
Q4 2022 £11,291,977 31 Dec 2022 10-K 01 Apr 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.